Circulation Reports
Online ISSN : 2434-0790
Epidemiology
Incidence Rate of Hospitalization for Heart Failure in a Japanese City ― An Updated Reference for Japan’s Aging Society ―
Kyohei Marume, Soshiro Ogata, Ryota Kaichi, Michikazu Nakai, Masanobu Ishii, Takayuki Mori, Soichi Komaki, Hiroaki Kusaka, Reiko Toida, Kazumasa Kurogi, Yoshitaka Iwanaga, Yoshihiro Miyamoto, Nobuyasu Yamamoto, on behalf of Nobeoka Heart Study Investigators
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2022 Volume 4 Issue 3 Pages 116-122

Details
Abstract

Background:The prevalence of heart failure (HF) is increasing in aging societies, such as Japan. The current incidence rate (IR) of HF hospitalization in Japan is unknown.

Methods and Results:We conducted a regional population-based study assessing the IR of HF hospitalization in Nobeoka City. Data were collected over a period of 3 years from all patients with HF admitted for the first time to hospitals and clinics. 406 HF hospitalizations were registered (54% female; mean age 82 years). The IR of HF hospitalization was 129/100,000 person-years. The difference in the IR between women and men was not significant (131 vs. 127/100,000 person-years, respectively; P=0.767). The age-adjusted IR in the 2015 Japanese population was 105/100,000 person-years. According to 5-year age bands, the IR of HF hospitalization gradually increased up to 60–70 years of age, then increased rapidly in those aged ≥95 years for both sexes. The IR ratio compared with age <65 years was higher in women than men in each older age group.

Conclusions:In this population-based study, the current IR of HF hospitalization in a region of Japan was higher than the IR from another study conducted in a different region in early 2000. By presenting detailed age-related data, the research findings will contribute to estimating the number of HF hospitalizations in other areas of Japan.

Content from these authors
© 2022, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top